TFEB在亨廷顿病中的作用
Javier Ojalvo-Pacheco1, Sokhna M S Yakhine-Diop1,2,3, José M Fuentes1,2,3
1Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, 10003 Caceres, Spain.
Biology
|April 26, 2024
概括
亨廷顿病涉及突变的亨廷丁蛋白聚合. 通过转录因子EB (TFEB) 增强自可能会清除这些聚合物,但需要进一步的研究来确认其治疗潜力.
科学领域:
- 神经退行性疾病的神经退行性疾病
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 亨廷顿病 (HD) 是一种神经退行性疾病,由亨廷丁 (HTT) 基因的CAG重复扩张引起.
- 这种扩张导致突变的亨廷丁蛋白 (mHTT) 聚合,通过各种细胞功能障碍损害神经元功能.
- 自和溶酶体通路对于清除mHTT至关重要,它们的功能障碍对HD的发病有显著的贡献.
研究的目的:
- 研究转录因子EB (TFEB) 在调节自身的作用,用于潜在的亨廷顿病治疗.
- 探索是否增强TFEB活性可以促进突变的亨廷丁聚合物的清除和改善疾病表型.
主要方法:
- 对TFEB作为自和 lysosomal biogenesis的主调节器的功能现有证据的审查.
- 在亨廷顿病模型的背景下研究TFEB调制的研究分析.
- 检查关于TFEB过度表达及其对mHTT聚合和疾病进展的影响的相互矛盾的发现.
主要成果:
- TFEB控制了参与自细胞形成, lysosomal 功能和自流动的关键基因.
- 一些研究表明,TFEB激活有助于mHTT总体清除,并改善HD表型.
- 相反,其他研究表明,TFEB过度表达可能通过促进mHTT联合聚合而加剧HD.
结论:
- 调节TFEB活性通过增强细胞内清除机制,为亨廷顿病提供了潜在的治疗策略.
- 相互矛盾的结果凸显出需要进一步调查TFEB在不同高清模型中的确切作用和安全性.
- 确认TFEB的疗效和安全性至关重要,然后再考虑它作为一种可行的治疗方法来治疗mHTT介导的毒性.
更多相关视频
相关概念视频
General Transcription Factors
5.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.3K
Transcription Factors
75.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.8K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Enzyme-linked Receptors
78.3K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.3K


